Antidepressant Overdose!

Slides:



Advertisements
Similar presentations
Other Medicines. Andrenergic Antagonists (Blockers) Bind to receptor site but do not cause an action Bind to receptor site but do not cause an action.
Advertisements

Janey, Kevin, & Brittany Major Depression & Bipolar Disorder.
Hyponatremia and Other Critical Electrolyte Abnormalities
Pharmaceutical Care of People with Depression
Monoamine oxidase inhibitors Monoamine Oxidase Inhibitors (MAOIs) are a class of powerful antidepressant drugs. They are particularly effective in treating.
Chapter 16 Depression. Two Major Categories of Mood Disorder Major depressive disorder (unipolar): Lengthy, uninterrupted periods of depressed mood. Manic.
PSYCHOPATHOLOGY.  Developed in the 1960s  Monoamine-oxidase inhibitors (MAOIs)  Increase the amount of Noradrenaline (Norepinephrine) in the synapse.
Opioids & Sedatives Toxicity
1 Neonatal Adverse Events Associated with in utero SSRI/SNRI Exposure Robert Levin, M.D. Medical Reviewer DNDP FDA.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 32 Antidepressants.
Depression Ibrahim Sales, Pharm.D. Associate Professor of Clinical Pharmacy King Saud University
SSRIs & Antidepressants
Depression in Norway By Jørgen and Philip.
Local Anesthetics Ed Bilsky, Ph.D. Department of Pharmacology University of New England.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Strategies to Switch Antidepressants Brittany Parmentier, PharmD PGY2 Behavioral Care Resident Butler University/Community Health Network This speaker.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
Introduction to the Biological Basis for Understanding Psychotropic Drugs.
Serotonin Syndrome (Toxicity) Sue Henderson
Drugs used in Anxiety & Panic Disorders
 A synapse divides at least 2 (usually more) neurons by ~20nm.  Presynaptic Neurons: carry impulses to the synapse  Postsynaptic Neurons: carry impulses.
By S.Bohlooli, Ph.D..  “An affective disorder characterized by loss of interest or pleasure in almost all a person’s usual activities or pastimes.”
Drugs used in Depression- New groups By Prof. Yieldez Bassiouni.
Fate of Local Anesthetics
Antidepressant drugs. Mood Disorder  The most common mood disorders are: 1. Major depression (unipolar depression). 2. Manic-depressive illness (bipolar.
for MHD & Therapeutics is proud to present And Now Here Is The Host... Insert Name Here.
TCA and Serotonin Re-Uptake Inhibitors Rama B. Rao, MD Bellevue/New York University Medical Center.
Case study Which antidepressant Dr. Matthew Miller.
Antidepressant drugs. Depression: is a disorder of mood rather than disturbance of thought or cognition. It is postulated that depression is due to deficiency.
Depression and Its Treatment Les Secrest, M.D.. Worldwide Depression accounts for a high level of disability and decreased functioning.
Drugs used in the treatment of affective disorders Dr. Vidumini De Silva.
Anxiolytic , Sedative and Hypnotic Drugs
 : Monoamine hypothesis of depression asserts that depression is caused by functional insufficiency of monoamine neurotransmitter (norepinephrine, serotonin.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
ANTIDEPRESSANTS Drugs which can Elevate Mood (Mood Elevators)
By dr.safeyya alchalabi
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
ADHD.
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Psychiatric Medications
Treatment Biomedical Module 73.
Antidepressant-Induced Sexual Dysfunction
β-adrenergic antagonists
Drugs Used for Mood Disorders
IRRITABLE BOWEL SYNDROME
Drugs used in Depression- Prof. Yieldez Bassiouni
EPIDEMIOLOGY TCA & MAOI first-generation antidepressant.
Pharmacology of central Neurotransmitters Prof. Yieldez Bassiouni
Drugs used in Depression- Prof. Yieldez Bassiouni
AFFECTIVE DISORDERS Anxiety----uneasiness from apprehension and worry about possible events. Try psychotherapy first. benzodiazepenes: xanax/alprazolam.
Drugs that bind on biogenic amine transporters
Antidepressants: pharmacodynamics
School of Pharmacy, University of Nizwa
School of Pharmacy, University of Nizwa
PHARMACOTHERAPY - I PHCY 310
Chapter 9: Community Pharmacy
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction.
TCA Poisoning.
CNS Stimulants Defination
Antidepressant Discontinuation Syndrome
Antidepressant drugs.
Drugs used in Depression- Prof. Yieldez Bassiouni
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Opioids & Sedatives Toxicity
Drugs used in Depression-
ADDICTION
Dr James Ovens Consultant Psychiatrist Tandridge CMHRS
Drugs Used in Depression (New group)
Tricyclic antidepressants (TCA)
Presentation transcript:

Antidepressant Overdose! Aref Melibary MD, FRCPC, DABEM Assistant Professor of Emergency Medicine Consultant Emergency Medicine & Critical Care Medicine Dept. of Emergency Medicine King Saud University Medical City dr_aref@hotmail.com

What’s Available? MAOI’s TCA SSRI SNRI

Monoamine Oxidase Inhibitors (MAOIs) Bind irreversibly to monoamine oxidase thereby preventing inactivation of biogenic amines such as norepinephrine, dopamine and serotonin leading to increased synaptic levels.

What Happens in MAOI Toxicity?

TCA’s

How many different MOA do TCA’s have? 3 4 5 6 7

How many different MOA do TCA’s have? 3 4 5 6 7

TCA’s Major Pharmacodynamic Effects

Peripheral & Central Effects of TCA’S

WHAT’S ABNORMAL?

Sinus Tachycardia Prolonged QT Interval Widening of the QRS interval RAD Prominent R in aVR

Specific Management Plasma Alkalinization (NaHCO3/ Hyperventilation) Sodium Load (NaHCO3 or 3% Saline)

Plasma Alkalinization Promotes TCA protein binding Plasma proteins act as a sink that sequesters TCA’s away from the sites of toxicity Increases the non-ionized form of the drug which UNBINDS TCA’s from Na-Channels

Sodium Load Leads to over-riding Na-Channel Blockade due to an increased Na concentration gradient across the cell membrane

SSRI’s

Simple Facts Mainstay for treatment of depression SSRIs have a wide therapeutic index Although they are safer in overdose than MAOIs and TCAs, they do have therapeutic limitations, such as the long delay until onset of antidepressant effect (variable) Rarely fatal, with ingestions of up to 30 times the daily dose associated with few or no symptoms

QTc prolongation Seizures

Remember SSRIs may be associated with SIADH at therapeutic doses Most cases of hyponatremia develop within 1 month and frequently within the first 2 weeks

Diagnostic Strategies and Management? NON SPECIFIC!!

Serotonin Syndrome

Simple Facts Potentially lethal condition Excess serotonin accumulation in the synaptic cleft Likely to develop when drugs from different classes are combined, e.g.increased release and impaired uptake Syndrome occurs in approximately 14 to16 % of persons who overdose on SSRIs

Clinical Features

Management

Hunter’s Criteria

Differential consideration for Serotonin Syndrome

Management Discontinue the offending agent Supportive Cyproheptadine (Serotonin Antagonist)

Discontinuation Syndrome Rarely life-threatening Can result in significant discomfort Typically starts within 3 days after therapy is stopped

Signs & Symptoms 6 Categories Disequilibrium (dizziness, ataxia) Sleep disturbances Gastrointestinal symptoms Affective symptoms (irritability, anxiety) Sensory symptoms (electric shock–like sensation, paresthesias) General somatic symptoms (H/A, tremor, anorexia, diaphoresis)

QUESTIONS? dr_aref@hotmail.com